Anti-rasburicase antibodies induce clinical refractoriness by inhibiting the enzyme catalytic activity.
Riccardo MoiaElena BoggioLuca GigliottiElena CrisàLorenzo De PaoliGloria Margiotta CasaluciRoberta RollaAndrea PatriarcaGianluca GaidanoUmberto DianzaniRiccardo BrunaPublished in: Hematological oncology (2020)
Keyphrases